These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11087679)

  • 1. Purification of GSK-3 by affinity chromatography on immobilized axin.
    Primot A; Baratte B; Gompel M; Borgne A; Liabeuf S; Romette JL; Jho EH; Costantini F; Meijer L
    Protein Expr Purif; 2000 Dec; 20(3):394-404. PubMed ID: 11087679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of CK1 by affinity chromatography on immobilised axin.
    Reinhardt J; Ferandin Y; Meijer L
    Protein Expr Purif; 2007 Jul; 54(1):101-9. PubMed ID: 17434749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
    Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
    Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3.
    Wang QM; Roach PJ; Fiol CJ
    Anal Biochem; 1994 Aug; 220(2):397-402. PubMed ID: 7978284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding.
    Webster MT; Rozycka M; Sara E; Davis E; Smalley M; Young N; Dale TC; Wooster R
    Genes Chromosomes Cancer; 2000 Aug; 28(4):443-53. PubMed ID: 10862053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice.
    Lucas JJ; Hernández F; Gómez-Ramos P; Morán MA; Hen R; Avila J
    EMBO J; 2001 Jan; 20(1-2):27-39. PubMed ID: 11226152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
    Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
    Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear glycogen and glycogen synthase kinase 3.
    Ragano-Caracciolo M; Berlin WK; Miller MW; Hanover JA
    Biochem Biophys Res Commun; 1998 Aug; 249(2):422-7. PubMed ID: 9712712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine dephosphorylation and concurrent inactivation of protein kinase FA/GSK-3 alpha by genistein in A431 cells.
    Yu JS; Yang SD
    J Cell Biochem; 1994 Sep; 56(1):131-41. PubMed ID: 7806586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos.
    He X; Saint-Jeannet JP; Woodgett JR; Varmus HE; Dawid IB
    Nature; 1995 Apr; 374(6523):617-22. PubMed ID: 7715701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide substrates suitable for assaying glycogen synthase kinase-3 in crude cell extracts.
    Welsh GI; Patel JC; Proud CG
    Anal Biochem; 1997 Jan; 244(1):16-21. PubMed ID: 9025901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreastatin, a chromogranin-A-derived peptide, inhibits insulin-stimulated glycogen synthesis by activating GSK-3 in rat adipocytes.
    González-Yanes C; Sánchez-Margalet V
    Biochem Biophys Res Commun; 2001 Nov; 289(1):282-7. PubMed ID: 11708813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth.
    Mazor M; Kawano Y; Zhu H; Waxman J; Kypta RM
    Oncogene; 2004 Oct; 23(47):7882-92. PubMed ID: 15361837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the Axin and Frat binding region of glycogen synthase kinase-3.
    Fraser E; Young N; Dajani R; Franca-Koh J; Ryves J; Williams RS; Yeo M; Webster MT; Richardson C; Smalley MJ; Pearl LH; Harwood A; Dale TC
    J Biol Chem; 2002 Jan; 277(3):2176-85. PubMed ID: 11707456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenopus axin interacts with glycogen synthase kinase-3 beta and is expressed in the anterior midbrain.
    Hedgepeth CM; Deardorff MA; Klein PS
    Mech Dev; 1999 Feb; 80(2):147-51. PubMed ID: 10072781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin.
    Ferkey DM; Kimelman D
    J Biol Chem; 2002 May; 277(18):16147-52. PubMed ID: 11861647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder.
    Yang SD; Yu JS; Lee TT; Yang CC; Ni MH; Yang YY
    J Cell Biochem; 1995 Sep; 59(1):108-16. PubMed ID: 8530529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium falciparum glycogen synthase kinase-3: molecular model, expression, intracellular localisation and selective inhibitors.
    Droucheau E; Primot A; Thomas V; Mattei D; Knockaert M; Richardson C; Sallicandro P; Alano P; Jafarshad A; Baratte B; Kunick C; Parzy D; Pearl L; Doerig C; Meijer L
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):181-96. PubMed ID: 15023360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.